Tetracyclines have been shown to regulate
matrix metalloproteinase (
MMP) expression in numerous cell types with various
periodontal disease models. MMP-13, or
collagenase-3, has been shown to be induced by a number of osteotropic
cytokines and
hormones in osteoblastic cells. In this study, we studied MMP-13 gene expression and regulation in osteoblasts by chemically modified
tetracyclines (CMTs). Preliminary cytotoxicity studies indicated that 1-10 microg/ml of
CMT-8 did not result in statistically significant cell death. Additional fluorescent microscopy experiments indicated that
CMT-8 but not CMT-5 had a nuclear distribution within one hour of addition CMTs. Using primary rat calvarial osteoblastic cells obtained from 21-day old neonatal rats, we determined MMP-13 gene expression when stimulated by
parathyroid hormone (PTH),
interleukin (IL)-1b, or tumour
necrosis factor (
TNF)-alpha in the presence or absence of
CMT-8 or -5. Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) using total
RNA was used to determine relative expression of MMP-13 compared to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a constitutively expressed housekeeping gene. Results indicate that all agents were consistently able to induce MMP-13 expression in primary calvarial osteoblastic cells. However,
CMT-8 inhibited MMP-13 expression from IL-1b and PTH stimulated cells while having little effect on
TNF-alpha stimulated MMP-13 expression. In contrast, CMT-5 only inhibited PTH stimulated MMP-13 expression, with no effect on IL-1b or
TNF-alpha stimulated MMP-13 expression. These results suggest that
CMT-8 and CMT-5 may differentially affect cell signaling pathways in osteoblastic cells that mediate MMP-13 gene expression.